Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7324 p672
6 November 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Patients need more information about complementary medicines

Patients are still not getting enough information about the use of complementary medicines and may not feel able to discuss the matter with health care professionals, new research has shown.

A survey carried out on behalf of Developing Patient Partnerships last month found that 71 per cent of people would like to discuss complementary medicine use with their GP or pharmacist. However, 38 per cent thought that most GPs disapprove of these medicines and 24 per cent said that they would be reluctant to tell their GPs that they were taking them. In addition, 29 per cent of people surveyed said that they would stop taking their prescription medicine or over-the-counter medicine if they were going to use complementary medicine. Two thirds of the people surveyed said they were unclear about which complementary medicines are safe and 40 per cent of people were unaware of the dangers of mixing natural remedies with other medicines.

Edzard Ernst, director, complementary medicine, Peninsula Medical School, Exeter, commented: “These data confirm previous surveys suggesting that patients’ need for information on complementary and alternative medicine is huge. Pharmacists should put themselves in a position where they can satisfy this need.” He added: “Talking about complementary medicine is all very well but, if this talk is not based on evidence, it is not useful, perhaps even the opposite. As the evidence in CAM is still very limited, this also means we need more CAM research and more dedicated funds to carry it out.”

DPP guides Developing Patient Partnerships has produced a guide for health professionals called “Talking about complementary medicine” and a patient booklet called “Making complementary medicine work for you”. They can be obtained through primary care organisations that are members of DPP.

Back to Top


©The Pharmaceutical Journal